Jun 20, 2023 08:02AM
Jun 20, 2023 08:00AM
Jun 5, 2023 09:27AM
Jun 5, 2023 08:00AM
May 15, 2023 04:15PM
Mar 31, 2023 04:30PM
Mar 31, 2023 04:28PM Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial Results
Dec 14, 2022 08:30AM
Nov 14, 2022 08:00AM
Sep 14, 2022 08:01AM
Sep 14, 2022 08:00AM
Aug 29, 2022 08:00AM
Aug 29, 2022 06:38AM
Aug 26, 2022 08:04AM Timber Pharmaceuticals Inc. (TMBR) Reports Publication of Results from Phase 2b CONTROL Study of TMB-001
Aug 26, 2022 08:00AM
Aug 11, 2022 05:20PM
Jun 23, 2022 08:00AM
May 31, 2022 08:06AM
May 31, 2022 08:00AM
May 12, 2022 04:10PM
Apr 28, 2022 08:07AM Timber Pharmaceuticals Inc. (TMBR) Granted FDA Fast Track Designation for TMB-001 in Severe Subtypes of Congenital
Apr 28, 2022 08:00AM
Mar 31, 2022 05:44PM
Mar 25, 2022 08:00AM
Mar 25, 2022 07:32AM
Mar 25, 2022 07:30AM
Mar 25, 2022 07:30AM
Feb 3, 2022 08:03AM Timber Pharmaceuticals Inc. (TMBR) Announces Positive End-of-Phase 2 Meeting with FDA for TMB-001
Feb 3, 2022 08:00AM
Nov 15, 2021 04:15PM
Oct 7, 2021 09:11AM
Oct 1, 2021 08:00AM
Aug 24, 2021 08:00AM
Aug 10, 2021 08:00AM
May 26, 2021 04:27PM Timber Pharmaceuticals Inc. (TMBR) Reports Complete Patient Enrollment in Phase 2b CONTROL Study Evaluating TMB-001 in Congenital Ichthyosis
May 26, 2021 04:05PM
May 11, 2021 04:39PM
Apr 28, 2021 08:07AM
Apr 28, 2021 08:00AM
Mar 23, 2021 04:05PM
Mar 15, 2021 08:30AM
Jan 13, 2021 09:26AM Pre-Open Stock Movers 01/13: (MTRX) (TMBR) (INTC) Higher; (MARA) (PRTY) (URBN) Lower (more...)
Jan 12, 2021 05:43PM
Jan 12, 2021 04:23PM
Jan 12, 2021 04:22PM
Dec 15, 2020 08:03AM
Dec 15, 2020 08:00AM
Nov 12, 2020 04:53PM
Jul 1, 2020 08:00AM Timber Pharmaceuticals Announces All CONTROL Study Sites Open and Enrolling Patients with Moderate to Severe Congenital Ichthyosis

323,716 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All